<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as an entry receptor, with virus entry enhanced by cellular transmembrane serine protease 2 (TMPRSS2), which primes the spike protein of the virus
 <sup>
  <xref ref-type="bibr" rid="CR55">55</xref>,
  <xref ref-type="bibr" rid="CR56">56</xref>
 </sup>. 
 <italic>ACE2</italic> is an X chromosome-encoded gene that is downregulated by oestrogens
 <sup>
  <xref ref-type="bibr" rid="CR57">57</xref>
 </sup> and exhibits tissue-specific expression patterns
 <sup>
  <xref ref-type="bibr" rid="CR39">39</xref>
 </sup>. Differences in 
 <italic>ACE2</italic> expression may be driven by sex-differential expression of 
 <italic>ACE2</italic> variants
 <sup>
  <xref ref-type="bibr" rid="CR58">58</xref>–
  <xref ref-type="bibr" rid="CR60">60</xref>
 </sup>. ACE2 is associated with interferon gene expression
 <sup>
  <xref ref-type="bibr" rid="CR61">61</xref>,
  <xref ref-type="bibr" rid="CR62">62</xref>
 </sup>, which in turn shows sex-specific regulation. The cell-intrinsic regulation of ACE2 expression may change with age, in response to changing levels of sex steroids, or following viral challenge. TMPRSS2 is regulated by androgen receptor signalling in prostate cells
 <sup>
  <xref ref-type="bibr" rid="CR63">63</xref>
 </sup>. Initial investigations have not demonstrated a significant difference in 
 <italic>TMPRSS2</italic> mRNA expression in lung tissue from males and females, but it is unknown whether androgens may impact expression in the setting of infection with SARS-CoV-2 (refs
 <sup>
  <xref ref-type="bibr" rid="CR63">63</xref>,
  <xref ref-type="bibr" rid="CR64">64</xref>
 </sup>) or whether the level of expression has an impact on SARS-CoV-2 burden. Further research is needed to determine whether sex-biased expression of 
 <italic>ACE2</italic>, coupled with the regulation of 
 <italic>TMPRSS2</italic> by androgens, increases SARS-CoV-2 susceptibility of males compared with females.
</p>
